000 | 01895 a2200529 4500 | ||
---|---|---|---|
005 | 20250516102249.0 | ||
264 | 0 | _c20130222 | |
008 | 201302s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0039953 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBian, Minjuan | |
245 | 0 | 0 |
_aOverexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. _h[electronic resource] |
260 |
_bPloS one _c2012 |
||
300 |
_ae39953 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDopamine _xgenetics |
650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xchemically induced |
650 | 0 | 4 |
_aOncogene Proteins _xgenetics |
650 | 0 | 4 |
_aParkinsonian Disorders _xgenetics |
650 | 0 | 4 | _aPeroxiredoxins |
650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xgenetics |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
650 | 0 | 4 | _aProtein Deglycase DJ-1 |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xbiosynthesis |
650 | 0 | 4 |
_aalpha-Synuclein _xgenetics |
700 | 1 | _aLiu, Jie | |
700 | 1 | _aHong, Xiaoqi | |
700 | 1 | _aYu, Mei | |
700 | 1 | _aHuang, Yufang | |
700 | 1 | _aSheng, Zhejin | |
700 | 1 | _aFei, Jian | |
700 | 1 | _aHuang, Fang | |
773 | 0 |
_tPloS one _gvol. 7 _gno. 6 _gp. e39953 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0039953 _zAvailable from publisher's website |
999 |
_c21941971 _d21941971 |